{
    "status": "ok",
    "totalResults": 12,
    "articles": [
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Treace Medical Concepts (NASDAQ:TMCI) Shares Gap Up to $8.76",
            "description": "Treace Medical Concepts, Inc. (NASDAQ:TMCI \u2013 Get Free Report)\u2019s stock price gapped up before the market opened on Friday . The stock had previously closed at $8.76, but opened at $9.00. Treace Medical Concepts shares last traded at $8.82, with a volume of 14,\u2026",
            "url": "https://www.etfdailynews.com/2023/12/01/treace-medical-concepts-nasdaqtmci-shares-gap-up-to-8-76/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/treace-medical-concepts-inc-logo.png&w=240&h=240&zc=2",
            "publishedAt": "2023-12-01T15:48:49Z",
            "content": "Treace Medical Concepts, Inc. (NASDAQ:TMCI \u2013 Get Free Report)\u2019s stock price gapped up before the market opened on Friday . The stock had previously closed at $8.76, but opened at $9.00. Treace Medica\u2026 [+4748 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Treace Medical Concepts Reports Third Quarter 2023 Financial Results",
            "description": "(marketscreener.com) PONTE VEDRA, Fla., Nov. 09, 2023 -- Treace Medical Concepts, Inc. , a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus through its Lapiplasty\u00ae 3D Bunion Correction\u00ae Procedure, today reporte\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TREACE-MEDICAL-CONCEPTS-I-121986239/news/Treace-Medical-Concepts-Reports-Third-Quarter-2023-Financial-Results-45291454/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-11-09T21:06:02Z",
            "content": "PONTE VEDRA, Fla., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (Treace or the Company) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical t\u2026 [+36804 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Treace Medical Concepts (NASDAQ:TMCI) Stock Price Down 3.9%",
            "description": "Treace Medical Concepts, Inc. (NASDAQ:TMCI \u2013 Get Free Report)\u2019s stock price traded down 3.9% on Tuesday . The company traded as low as $8.44 and last traded at $8.49. Approximately 131,564 shares changed hands during mid-day trading, a decline of 76% from the\u2026",
            "url": "https://www.etfdailynews.com/2023/11/28/treace-medical-concepts-nasdaqtmci-stock-price-down-3-9/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/treace-medical-concepts-inc-logo.png&w=240&h=240&zc=2",
            "publishedAt": "2023-11-28T20:14:49Z",
            "content": "Treace Medical Concepts, Inc. (NASDAQ:TMCI \u2013 Get Free Report)\u2019s stock price traded down 3.9% on Tuesday . The company traded as low as $8.44 and last traded at $8.49. Approximately 131,564 shares cha\u2026 [+4589 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Treace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Bought by Sectoral Asset Management Inc.",
            "description": "Sectoral Asset Management Inc. lifted its position in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI \u2013 Free Report) by 3.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission.\u2026",
            "url": "https://www.etfdailynews.com/2023/11/27/treace-medical-concepts-inc-nasdaqtmci-shares-bought-by-sectoral-asset-management-inc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/treace-medical-concepts-inc-logo.png&w=240&h=240&zc=2",
            "publishedAt": "2023-11-27T16:28:43Z",
            "content": "Sectoral Asset Management Inc. lifted its position in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI \u2013 Free Report) by 3.5% during the second quarter, according to the company in its most recen\u2026 [+4885 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Lisanti Capital Growth LLC Buys Shares of 179,605 Treace Medical Concepts, Inc. (NASDAQ:TMCI)",
            "description": "Lisanti Capital Growth LLC bought a new stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI \u2013 Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 179\u2026",
            "url": "https://www.etfdailynews.com/2023/11/30/lisanti-capital-growth-llc-buys-shares-of-179605-treace-medical-concepts-inc-nasdaqtmci/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/treace-medical-concepts-inc-logo.png&w=240&h=240&zc=2",
            "publishedAt": "2023-11-30T17:24:48Z",
            "content": "Lisanti Capital Growth LLC bought a new stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI \u2013 Free Report) during the second quarter, according to the company in its most recent 13F filing with the S\u2026 [+4498 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Treace Medical Concepts, Inc.",
            "title": "Treace Medical Concepts Reports Third Quarter 2023 Financial Results",
            "description": "PONTE VEDRA, Fla., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (\u201cTreace\u201d or the \u201cCompany\u201d) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions) th\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/09/2777792/0/en/Treace-Medical-Concepts-Reports-Third-Quarter-2023-Financial-Results.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/e6af4ccc-19b1-4fe0-948f-436f2b9d2ea5",
            "publishedAt": "2023-11-09T21:05:00Z",
            "content": "PONTE VEDRA, Fla., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (Treace or the Company) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical t\u2026 [+36785 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Treace Medical Concepts, Inc. (NASDAQ:TMCI) Stake Decreased by Oak Ridge Investments LLC",
            "description": "Oak Ridge Investments LLC lessened its holdings in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI \u2013 Free Report) by 3.1% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. \u2026",
            "url": "https://www.etfdailynews.com/2023/11/05/treace-medical-concepts-inc-nasdaqtmci-stake-decreased-by-oak-ridge-investments-llc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/treace-medical-concepts-inc-logo.png&w=240&h=240&zc=2",
            "publishedAt": "2023-11-05T14:02:54Z",
            "content": "Oak Ridge Investments LLC lessened its holdings in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI \u2013 Free Report) by 3.1% during the second quarter, according to the company in its most recent F\u2026 [+5033 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Driehaus Capital Management LLC Raises Stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI)",
            "description": "Driehaus Capital Management LLC increased its stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI \u2013 Free Report) by 96.4% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owne\u2026",
            "url": "https://www.etfdailynews.com/2023/12/03/driehaus-capital-management-llc-raises-stake-in-treace-medical-concepts-inc-nasdaqtmci/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/treace-medical-concepts-inc-logo.png&w=240&h=240&zc=2",
            "publishedAt": "2023-12-03T16:22:51Z",
            "content": "Driehaus Capital Management LLC increased its stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI \u2013 Free Report) by 96.4% in the second quarter, according to its most recent 13F filing with the Secur\u2026 [+5004 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Treace Medical Concepts (NASDAQ:TMCI) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPS",
            "description": "Treace Medical Concepts (NASDAQ:TMCI \u2013 Get Free Report) announced its earnings results on Thursday. The company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.26) by ($0.02), reports. Treace Medical Concepts had a n\u2026",
            "url": "https://www.etfdailynews.com/2023/11/12/treace-medical-concepts-nasdaqtmci-posts-quarterly-earnings-results-misses-expectations-by-0-02-eps/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/treace-medical-concepts-inc-logo.png&w=240&h=240&zc=2",
            "publishedAt": "2023-11-12T13:34:42Z",
            "content": "Treace Medical Concepts (NASDAQ:TMCI \u2013 Get Free Report) announced its earnings results on Thursday. The company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of \u2026 [+4234 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Morgan Stanley Cuts Treace Medical Concepts (NASDAQ:TMCI) Price Target to $14.00",
            "description": "Treace Medical Concepts (NASDAQ:TMCI \u2013 Get Free Report) had its price objective decreased by equities research analysts at Morgan Stanley from $30.00 to $14.00 in a research note issued on Monday, Benzinga reports. The brokerage currently has an \u201coverweight\u201d \u2026",
            "url": "https://www.etfdailynews.com/2023/11/13/morgan-stanley-cuts-treace-medical-concepts-nasdaqtmci-price-target-to-14-00/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/treace-medical-concepts-inc-logo.png&w=240&h=240&zc=2",
            "publishedAt": "2023-11-13T16:20:44Z",
            "content": "Treace Medical Concepts (NASDAQ:TMCI \u2013 Get Free Report) had its price objective decreased by equities research analysts at Morgan Stanley from $30.00 to $14.00 in a research note issued on Monday, Be\u2026 [+4785 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Treace Medical Concepts (NASDAQ:TMCI) Price Target Cut to $11.00 by Analysts at Stifel Nicolaus",
            "description": "Treace Medical Concepts (NASDAQ:TMCI \u2013 Free Report) had its price target cut by Stifel Nicolaus from $28.00 to $11.00 in a research report released on Friday morning, Benzinga reports. They currently have a buy rating on the stock. A number of other equities \u2026",
            "url": "https://www.etfdailynews.com/2023/11/11/treace-medical-concepts-nasdaqtmci-price-target-cut-to-11-00-by-analysts-at-stifel-nicolaus/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/treace-medical-concepts-inc-logo.png&w=240&h=240&zc=2",
            "publishedAt": "2023-11-11T12:40:45Z",
            "content": "Treace Medical Concepts (NASDAQ:TMCI \u2013 Free Report) had its price target cut by Stifel Nicolaus from $28.00 to $11.00 in a research report released on Friday morning, Benzinga reports. They currently\u2026 [+3938 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "InvestorsObserver"
            },
            "author": "InvestorsObserver",
            "title": "Healthcare Stocks on the Move Friday: INVO, BACK, DOCS, ANNX, FBIO, TMCI, ADPT, CANO",
            "description": "These Healthcare stocks are trading higher:\n-Invo Bioscience Inc (INVO) stock is trading at $1.30, an increase of $0.6, or 84.92%, on high volume.  Invo Bioscience Inc gets a Sen",
            "url": "https://www.investorsobserver.com/news/stock-update/healthcare-stocks-on-the-move-friday-invo-back-docs-annx-fbio-tmci-adpt-cano",
            "urlToImage": "https://s3.amazonaws.com/images.investorsobserver.com/wp-content/uploads/2019/09/10145424/190910-MedicalDevices.jpg",
            "publishedAt": "2023-11-10T14:16:02Z",
            "content": "These Healthcare stocks are trading higher:\r\n-Invo Bioscience Inc (INVO) stock is trading at $1.30, an increase of $0.6, or 84.92%, on high volume. Invo Bioscience Inc gets a Sentiment Score of Beari\u2026 [+2256 chars]"
        }
    ]
}